Zhixin Xu

857 total citations
16 papers, 659 citations indexed

About

Zhixin Xu is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Zhixin Xu has authored 16 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Zhixin Xu's work include Genomics, phytochemicals, and oxidative stress (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Synthesis and biological activity (2 papers). Zhixin Xu is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Synthesis and biological activity (2 papers). Zhixin Xu collaborates with scholars based in China, United States and Australia. Zhixin Xu's co-authors include Jill E. Porter, W. Berthold, George K. Ehrlich, Cheryl Spence, Alicia V. Palleroni, Wen Pan, Mary C. Graves, Pascal Bailon, Marlene Modi and Mei‐Jun Zhu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Bioconjugate Chemistry.

In The Last Decade

Zhixin Xu

16 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhixin Xu China 9 271 136 112 94 87 16 659
Zhifeng Wu China 18 393 1.5× 254 1.9× 48 0.4× 117 1.2× 54 0.6× 44 988
Lijie Pan China 21 388 1.4× 25 0.2× 56 0.5× 71 0.8× 103 1.2× 39 824
Steven W. Andrews United States 17 191 0.7× 28 0.2× 46 0.4× 78 0.8× 73 0.8× 23 725
Steven Duniho United States 11 437 1.6× 272 2.0× 22 0.2× 39 0.4× 515 5.9× 16 1.2k
Yannan Qin China 18 653 2.4× 30 0.2× 43 0.4× 151 1.6× 77 0.9× 40 1.0k
Aiko Hasegawa Japan 11 291 1.1× 19 0.1× 58 0.5× 68 0.7× 129 1.5× 18 920
Jingjing Yu China 22 787 2.9× 51 0.4× 70 0.6× 62 0.7× 367 4.2× 82 1.6k
Jianhua Wang China 17 310 1.1× 16 0.1× 30 0.3× 42 0.4× 148 1.7× 39 790
Yuka Ikeda Japan 17 522 1.9× 35 0.3× 12 0.1× 69 0.7× 79 0.9× 35 899
Ramasatyaveni Geesala United States 12 180 0.7× 20 0.1× 26 0.2× 84 0.9× 50 0.6× 26 475

Countries citing papers authored by Zhixin Xu

Since Specialization
Citations

This map shows the geographic impact of Zhixin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixin Xu more than expected).

Fields of papers citing papers by Zhixin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixin Xu. The network helps show where Zhixin Xu may publish in the future.

Co-authorship network of co-authors of Zhixin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixin Xu. A scholar is included among the top collaborators of Zhixin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixin Xu. Zhixin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Hongbin, Qiyu Tian, Zhixin Xu, ‬Min Du, & Mei‐Jun Zhu. (2023). Metabolomic profiling for the preventive effects of dietary grape pomace against colorectal cancer. The Journal of Nutritional Biochemistry. 116. 109308–109308. 4 indexed citations
2.
Wang, Yaling, Yunyun Liang, Yisheng Gao, et al.. (2022). Proteomic Analysis of Silk Fibroin Reveals Diverse Biological Function of Different Degumming Processing From Different Origin. Frontiers in Bioengineering and Biotechnology. 9. 777320–777320. 8 indexed citations
3.
Zhao, Yahong, Yunyun Liang, Zhixin Xu, et al.. (2022). Exosomal miR-673-5p from fibroblasts promotes Schwann cell-mediated peripheral neuron myelination by targeting the TSC2/mTORC1/SREBP2 axis. Journal of Biological Chemistry. 298(3). 101718–101718. 18 indexed citations
4.
Zhao, Yahong, Jin Liu, Yisheng Gao, et al.. (2022). Conductive biocomposite hydrogels with multiple biophysical cues regulate schwann cell behaviors. Journal of Materials Chemistry B. 10(10). 1582–1590. 19 indexed citations
5.
7.
Wang, Tao, et al.. (2021). Ameliorative Effect of Parishin C Against Cerebral Ischemia-Induced Brain Tissue Injury by Reducing Oxidative Stress and Inflammatory Responses in Rat Model. Neuropsychiatric Disease and Treatment. Volume 17. 1811–1823. 23 indexed citations
8.
Wang, Hongbin, et al.. (2021). Metabolomic Insights Into the Preventive Effects of Grape Pomace Against Colorectal Cancer. Current Developments in Nutrition. 5. 612–612. 2 indexed citations
9.
10.
Tian, Qiyu, Zhixin Xu, Xiaofei Sun, et al.. (2020). Grape pomace inhibits colon carcinogenesis by suppressing cell proliferation and inducing epigenetic modifications. The Journal of Nutritional Biochemistry. 84. 108443–108443. 24 indexed citations
11.
Xu, Chang, Erchao Li, Zhixin Xu, et al.. (2016). Molecular characterization and expression of AMP-activated protein kinase in response to low-salinity stress in the Pacific white shrimp Litopenaeus vannamei. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 198. 79–90. 31 indexed citations
12.
Brennan, Barbara J., Zhixin Xu, & Joseph F. Grippo. (2012). Evaluation of the Absolute Bioavailability of Pegylated Interferon Alfa-2a After Subcutaneous Administration to Healthy Male Volunteers: An Open-Label, Randomized, Parallel-Group Study. Clinical Therapeutics. 34(9). 1883–1891. 5 indexed citations
13.
Leijen, Suzanne, Mark R. Middleton, Patricia Tresca, et al.. (2011). Phase I (Ph) safety, pharmacodynamic (PD), and pharmacokinetic (PK) trial of a pure MEK inhibitor (i), RO4987655, in patients with advanced /metastatic solid tumor.. Journal of Clinical Oncology. 29(15_suppl). 3017–3017. 7 indexed citations
14.
Dolly, Saoirse, Joan Albanell, Françoise Kraeber‐Bodéré, et al.. (2011). First-in-human, safety, pharmacodynamic (PD) and pharmacokinetic (PK) trial of a first-in-class dual RAF/MEK inhibitor, RO5126766, in patients with advanced or metastatic solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 3006–3006. 4 indexed citations
15.
Chen, Longhua, et al.. (2003). Etiological analysis of the sequelae of radiotherapy for nasopharyngeal carcinoma: a follow-up study of 112 cases.. PubMed. 23(10). 1002–5. 2 indexed citations
16.
Bailon, Pascal, Alicia V. Palleroni, Cheryl Spence, et al.. (2001). Rational Design of a Potent, Long-Lasting Form of Interferon:  A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C. Bioconjugate Chemistry. 12(2). 195–202. 483 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026